Imerys S.A.
Imerys S.A. (NK.PA) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Imerys S.A. (NK.PA), featuring income statements, balance sheets, and cash flow data.
Imerys S.A. (NK.PA) Income Statement & Financial Overview
Review Imerys S.A. NK.PA income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $1.69B | $855.00M | $992.60M | $926.00M |
Cost of Revenue | $854.40M | $0.00 | $1.38B | $0.00 |
Gross Profit | $831.90M | $855.00M | -$384.20M | $926.00M |
Gross Profit Ratio | $0.49 | $1.00 | -$0.39 | $1.00 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $831.90M | $0.00 | -$505.40M | $0.00 |
Operating Expenses | $831.90M | $778.00M | $375.50M | $816.00M |
Total Costs & Expenses | $1.69B | $778.00M | $1.75B | $816.00M |
Interest Income | $0.00 | $0.00 | $18.80M | $16.00M |
Interest Expense | $0.00 | $12.00M | $212.20M | $0.00 |
Depreciation & Amortization | $0.00 | $0.00 | $170.30M | $59.00M |
EBITDA | -$62.50M | $77.00M | $282.00M | $108.00M |
EBITDA Ratio | -$0.04 | $0.09 | $0.28 | $0.12 |
Operating Income | $0.00 | $77.00M | $111.70M | $108.00M |
Operating Income Ratio | $0.00 | $0.09 | $0.11 | $0.12 |
Other Income/Expenses (Net) | $0.00 | -$77.00M | -$13.30M | -$29.00M |
Income Before Tax | $0.00 | $0.00 | $98.40M | $94.00M |
Income Before Tax Ratio | $0.00 | $0.00 | $0.10 | $0.10 |
Income Tax Expense | $306.60M | -$41.00M | $25.30M | $24.00M |
Net Income | $48.00M | -$285.00M | $141.70M | $69.00M |
Net Income Ratio | $0.03 | -$0.33 | $0.14 | $0.07 |
EPS | $0.57 | -$3.37 | $1.68 | $0.82 |
Diluted EPS | $0.57 | -$3.37 | $1.68 | $0.82 |
Weighted Avg Shares Outstanding | $84.45M | $84.45M | $84.52M | $84.43M |
Weighted Avg Shares Outstanding (Diluted) | $84.45M | $84.45M | $84.52M | $84.43M |
Over the last four quarters, Imerys S.A.'s revenue moved from $926.00M in Q1 2024 to $1.69B in Q4 2024. Operating income in Q4 2024 was $0.00, with a strong operating margin of N/A. Despite fluctuations in R&D and SG&A expenses, EBITDA for Imerys S.A. remained robust at -$62.50M, reflecting operational efficiency. Net income rose to $48.00M, with an EPS of $0.57. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan